General MedicationsTRANSDERMALStandard
EMSAM
SELEGILINE
Standard Dose
9MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview EMSAM is listed in Drugs@FDA under application 021708 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SELEGILINE Form and strength SYSTEM; TRANSDERMAL - 9MG Sponsor SOMERSET Submission history Latest submission status date: 2006-02-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview EMSAM is listed in Drugs@FDA under application 021708 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SELEGILINE Form and strength SYSTEM; TRANSDERMAL - 9MG Sponsor SOMERSET Submission history Latest submission status date: 2006-02-27 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.